Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CCKAR | P32238 | 1/20 | 0.44 |
| ▸ | CCKBR | P32239 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24344002 | 0.85 | GRN (0.51) | CA2CA1MME | |
| SCHEMBL6065018 | 0.84 | NAALAD2 (0.51) | HSD17B10CA2CA1CCKARCCKBR | |
| SCHEMBL27565835 | 0.84 | NAALAD2 (0.51) | HSD17B10CA2CA1CCKARCCKBR | |
| SCHEMBL18419393 | 0.81 | L3MBTL1 (0.52) | HPGDCA2CA1 | |
| SCHEMBL10657352 | 0.81 | L3MBTL1 (0.52) | HPGDCA2CA1 | |
| SCHEMBL12984761 | 0.81 | CA2 (0.47) | CA2CA1MME | |
| SCHEMBL3459202 | 0.81 | PYGL (0.50) | CCKARCCKBR | |
| SCHEMBL12984129 | 0.80 | CA2 (0.46) | KDM4EALDH1A1HPGDHSD17B10CA2 | |
| SCHEMBL12983737 | 0.80 | KDM4E (0.55) | KDM4EPOLBALDH1A1HPGDHSD17B10 | |
| SCHEMBL12984098 | 0.80 | CHRNB2 (0.56) | ALDH1A1CA2CA1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1801232-B1 | METHOD OF SCREENING TRANSMEMBRANE ENZYME INHIBITORY SUBSTANCE | TAKEDA PHARMACEUTICAL (JP) | 2012-03-14 | — | — | EP | disclosed |
| US-20080220445-A1 | Method of Screening Transmembrane Enzyme Inhibitory Substance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-09-11 | — | — | US | disclosed |
| EP-1801232-A1 | METHOD OF SCREENING TRANSMEMBRANE ENZYME INHIBITORY SUBSTANCE | Takeda Pharmaceutical Company Limited (JP) | 2007-06-27 | — | — | EP | disclosed |